A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Agents.

NCT00504777 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: rituximab [MabThera/Rituxan]
DRUG: Methotrexate

Sponsor

Hoffmann-La Roche